“It is very important that this drug was approved and reached the market,” UTMB’s Dr. Giulio Taglialatela tells the Daily News for a story on a study currently recruiting people for a clinic trail. “The ultimate goal is a cure, which I really hope we are on the right track to achieve,” Tagliatela said.